Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in Mild to Moderate Alzheimer's Disease
NCT01094340Phase 3Unknown
- Sponsor
- Banner Health
- Start
- Mar 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in Alzheimer's disease (AD), sponsored by Banner Health. Status: unknown.
02
Drugs
thalidomide
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01094340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01094340.